These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 3798126)
1. Hormonal therapy for lesions of the endometrium. Gal D Semin Oncol; 1986 Dec; 13(4 Suppl 4):33-6. PubMed ID: 3798126 [TBL] [Abstract][Full Text] [Related]
2. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia. Gal D; Edman CD; Vellios F; Forney JP Am J Obstet Gynecol; 1983 Jun; 146(3):316-22. PubMed ID: 6859142 [TBL] [Abstract][Full Text] [Related]
3. Progestin therapy in lesions of the endometrium. Wentz WB Semin Oncol; 1985 Mar; 12(1 Suppl 1):23-7. PubMed ID: 3975648 [TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia secondary to megestrol acetate for endometrial neoplasia. Rose PG Gynecol Oncol; 1996 Apr; 61(1):139-41. PubMed ID: 8626102 [TBL] [Abstract][Full Text] [Related]
5. Megestrol acetate: clinical experience. Schacter L; Rozencweig M; Canetta R; Kelley S; Nicaise C; Smaldone L Cancer Treat Rev; 1989 Mar; 16(1):49-63. PubMed ID: 2471590 [TBL] [Abstract][Full Text] [Related]
6. The impact of adjunctive metformin to progesterone for the treatment of non-atypical endometrial hyperplasia in a randomized fashion, a placebo-controlled, double blind clinical trial. Tehranian A; Ghahghaei-Nezamabadi A; Arab M; Khalagi K; Aghajani R; Sadeghi S J Gynecol Obstet Hum Reprod; 2021 Jun; 50(6):101863. PubMed ID: 32652300 [TBL] [Abstract][Full Text] [Related]
7. Metabolic effects associated with high-dose continuous megestrol acetate administration in the treatment of endometrial pathology. Güven M; Dikmen Y; Terek MC; Ozsaran AA; Itil IM; Erhan Y Arch Gynecol Obstet; 2001 Nov; 265(4):183-6. PubMed ID: 11789741 [TBL] [Abstract][Full Text] [Related]
8. Comparing the Administration of Letrozole and Megestrol Acetate in the Treatment of Women with Simple Endometrial Hyperplasia without Atypia: A Randomized Clinical Trial. Moradan S; Nikkhah N; Mirmohammadkhanai M Adv Ther; 2017 May; 34(5):1211-1220. PubMed ID: 28353144 [TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone receptor expression of decidual endometrium in a postmenopausal woman treated with tamoxifen and megestrol acetate. Cohen I; Shulman A; Altaras M; Tepper R; Cordoba M; Beyth Y Gynecol Obstet Invest; 1994; 38(2):127-9. PubMed ID: 7959340 [TBL] [Abstract][Full Text] [Related]
10. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin]. Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224 [TBL] [Abstract][Full Text] [Related]
12. A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia. Sharifzadeh F; Aminimoghaddam S; Kashanian M; Fazaeli M; Sheikhansari N Gynecol Endocrinol; 2017 Feb; 33(2):152-155. PubMed ID: 27690687 [TBL] [Abstract][Full Text] [Related]
13. Treatment of persistent endometrial hyperplasia with progestins. Wentz WB Am J Obstet Gynecol; 1966 Dec; 96(7):999-1004. PubMed ID: 5928460 [No Abstract] [Full Text] [Related]
14. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives. Shen ZQ; Zhu HT; Lin JF Obstet Gynecol; 2008 Aug; 112(2 Pt 2):465-7. PubMed ID: 18669766 [TBL] [Abstract][Full Text] [Related]
15. Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. Buzdar A; Jonat W; Howell A; Jones SE; Blomqvist C; Vogel CL; Eiermann W; Wolter JM; Azab M; Webster A; Plourde PV J Clin Oncol; 1996 Jul; 14(7):2000-11. PubMed ID: 8683230 [TBL] [Abstract][Full Text] [Related]
16. Uterine adenocarcinoma metastatic to the skin responsive to megestrol acetate. Spencer DM; Bigler LR; Wilkin JK; Gams RA J Dermatol Surg Oncol; 1994 Aug; 20(8):544-7. PubMed ID: 8056889 [TBL] [Abstract][Full Text] [Related]
17. Megestrol acetate in the treatment of metastatic carcinoma of the prostate. Venner P Oncology; 1992; 49 Suppl 2():22-7. PubMed ID: 1461622 [TBL] [Abstract][Full Text] [Related]
18. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin. Simpson AN; Feigenberg T; Clarke BA; Gien LT; Ismiil N; Laframboise S; Massey C; Ferguson SE Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246 [TBL] [Abstract][Full Text] [Related]
19. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer. Chen M; Jin Y; Li Y; Bi Y; Shan Y; Pan L Int J Gynaecol Obstet; 2016 Jan; 132(1):34-8. PubMed ID: 26493012 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia. Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]